GREY:IMVIF - Post by User
Comment by
PoorOpinionon Dec 18, 2018 12:12pm
79 Views
Post# 29129516
RE:RE:Target raised
RE:RE:Target raisedMarlborough wrote: Thanks avenueman.
For anyone who's interested:
https://dawsonjames.com/wp-content/uploads/2018/12/IMV-Update-12-14-2018-final.pdf
So it seems the Dawson James analyst believes we'll get an update from the FDA meeting in Jan (when the FDA send the minutes to IMV) rather than immediately after the meeting. I wonder if this is from an understanding of the FDA process or if IMV management have directed her on this?
Out of curiosity. She seems to have some details that I dont ever remember reading or hearing on the cc. For example "
In the trial, the BTB ranged from 1.5 to 30 cm, with average 9 cm.". Anybody read or heard that fact before?